{"id":"https://openalex.org/W2102271024","doi":"https://doi.org/10.1177/0269881110378370","title":"Instability of the ecstasy market and a new kid on the block: mephedrone","display_name":"Instability of the ecstasy market and a new kid on the block: mephedrone","alternate_titles":[],"publication_year":2010,"publication_date":"2010-09-08","ids":{"openalex":"https://openalex.org/W2102271024","doi":"https://doi.org/10.1177/0269881110378370","mag":"2102271024","pmid":"https://pubmed.ncbi.nlm.nih.gov/20826554"},"language":"en","primary_location":{"id":"doi:10.1177/0269881110378370","doi":"https://doi.org/10.1177/0269881110378370","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0269881110378370","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2102271024"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014583967","display_name":"Tibor M. Brunt","orcid":"https://orcid.org/0000-0001-5337-9649","observed_orcids":["https://orcid.org/0000-0001-5337-9649","https://orcid.org/0000-0003-2649-7855"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Tibor M Brunt","raw_affiliation_strings":["Drug Information and Monitoring System, Netherlands Institute of Mental Health and Addiction, Utrecht, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Information and Monitoring System, Netherlands Institute of Mental Health and Addiction, Utrecht, the Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067153016","display_name":"Anneke Poortman-van der Meer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I158244335","display_name":"Netherlands Forensic Institute","ror":"https://ror.org/04s2z4291","country_code":"NL","type":"facility","lineage":["https://openalex.org/I158244335"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Anneke Poortman","raw_affiliation_strings":["Netherlands Forensic Institute, The Hague, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Netherlands Forensic Institute, The Hague, the Netherlands","institution_ids":["https://openalex.org/I158244335"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111620863","display_name":"Raymond J.M. Niesink","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Raymond JM Niesink","raw_affiliation_strings":["Drug Information and Monitoring System, Netherlands Institute of Mental Health and Addiction, Utrecht, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Information and Monitoring System, Netherlands Institute of Mental Health and Addiction, Utrecht, the Netherlands","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071695786","display_name":"Wim van den Brink","orcid":"https://orcid.org/0000-0001-8301-0121","observed_orcids":["https://orcid.org/0000-0001-8301-0121","https://orcid.org/0000-0002-4493-2382"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Wim van den Brink","raw_affiliation_strings":["Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I887064364"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5014583967"],"corresponding_institution_ids":[],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":20.8107,"has_fulltext":false,"cited_by_count":238,"citation_normalized_percentile":{"value":0.99591607,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":100},"biblio":{"volume":"25","issue":"11","first_page":"1543","last_page":"1547"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12553","display_name":"Psychedelics and Drug Studies","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12842","display_name":"Youth, Drugs, and Violence","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mephedrone","display_name":"mephedrone","score":0.9679999947547913},{"id":"https://openalex.org/keywords/mdma","display_name":"MDMA","score":0.7400000095367432},{"id":"https://openalex.org/keywords/4-methylmethcathinone","display_name":"4-methylmethcathinone","score":0.9129999876022339},{"id":"https://openalex.org/keywords/ecstasy-tablets","display_name":"ecstasy tablets","score":0.6840000152587891},{"id":"https://openalex.org/keywords/craving","display_name":"craving","score":0.8949999809265137},{"id":"https://openalex.org/keywords/amphetamine-type-stimulants","display_name":"amphetamine-type stimulants","score":0.8759999871253967},{"id":"https://openalex.org/keywords/drug-substitution","display_name":"drug substitution","score":0.5649999976158142},{"id":"https://openalex.org/keywords/recreational-drug-use","display_name":"recreational drug use","score":0.7360000014305115},{"id":"https://openalex.org/keywords/netherlands","display_name":"Netherlands","score":0.8420000076293945}],"concepts":[{"id":"https://openalex.org/C2779488553","wikidata":"https://www.wikidata.org/wiki/Q625143","display_name":"Ecstasy","level":2,"score":0.9960108995437622},{"id":"https://openalex.org/C2779972045","wikidata":"https://www.wikidata.org/wiki/Q262613","display_name":"Mephedrone","level":3,"score":0.9916344285011292},{"id":"https://openalex.org/C2780876324","wikidata":"https://www.wikidata.org/wiki/Q69488","display_name":"MDMA","level":2,"score":0.9765408039093018},{"id":"https://openalex.org/C2778236026","wikidata":"https://www.wikidata.org/wiki/Q414242","display_name":"Cathinone","level":4,"score":0.6507943868637085},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5357835292816162},{"id":"https://openalex.org/C2910738821","wikidata":"https://www.wikidata.org/wiki/Q7708739","display_name":"Recreational Drug","level":3,"score":0.5152061581611633},{"id":"https://openalex.org/C2778961205","wikidata":"https://www.wikidata.org/wiki/Q1200715","display_name":"Designer drug","level":3,"score":0.46880772709846497},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.45565342903137207},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3634670376777649},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34797754883766174},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.321913480758667},{"id":"https://openalex.org/C2777193897","wikidata":"https://www.wikidata.org/wiki/Q179452","display_name":"Amphetamine","level":3,"score":0.31039467453956604},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.08049839735031128},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.07255604863166809}],"mesh":[{"descriptor_ui":"D000661","descriptor_name":"Amphetamine","qualifier_ui":"Q000600","qualifier_name":"supply & distribution","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008694","descriptor_name":"Methamphetamine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D008694","descriptor_name":"Methamphetamine","qualifier_ui":"Q000600","qualifier_name":"supply & distribution","is_major_topic":false},{"descriptor_ui":"D009426","descriptor_name":"Netherlands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013287","descriptor_name":"Illicit Drugs","qualifier_ui":"Q000600","qualifier_name":"supply & distribution","is_major_topic":true},{"descriptor_ui":"D013607","descriptor_name":"Tablets","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018817","descriptor_name":"N-Methyl-3,4-methylenedioxyamphetamine","qualifier_ui":"Q000600","qualifier_name":"supply & distribution","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1177/0269881110378370","doi":"https://doi.org/10.1177/0269881110378370","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0269881110378370","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:20826554","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20826554","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of psychopharmacology (Oxford, England)","raw_type":"Journal Article"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/a939b790-dd88-49eb-8153-f4f624582a42","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/instability-of-the-ecstasy-market-and-a-new-kid-on-the-block-mephedrone(a939b790-dd88-49eb-8153-f4f624582a42).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of psychopharmacology (Oxford, England), 25(11), 1543 - 1547. SAGE Publications Ltd","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/d7847c82-3f11-43c2-a4cd-8fa075ed5086","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/d7847c82-3f11-43c2-a4cd-8fa075ed5086","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Brunt, T M, Poortman, A, Niesink, R J M & van den Brink, W 2011, 'Instability of the ecstasy market and a new kid on the block: mephedrone', Journal of psychopharmacology (Oxford, England), vol. 25, no. 11, pp. 1543-1547. https://doi.org/10.1177/0269881110378370","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W1959591930","https://openalex.org/W1981585756","https://openalex.org/W1986217300","https://openalex.org/W1990627055","https://openalex.org/W2000376826","https://openalex.org/W2001759324","https://openalex.org/W2016790140","https://openalex.org/W2026781905","https://openalex.org/W2063173231","https://openalex.org/W2072549395","https://openalex.org/W2081023890","https://openalex.org/W2094570540","https://openalex.org/W2094896328","https://openalex.org/W2106287416","https://openalex.org/W2107911851","https://openalex.org/W2113396762","https://openalex.org/W2129182288","https://openalex.org/W2135019658","https://openalex.org/W2144875128","https://openalex.org/W2157382250","https://openalex.org/W2157400789","https://openalex.org/W2161225974","https://openalex.org/W2263772089","https://openalex.org/W4214666894"],"related_works":["https://openalex.org/W2107911851","https://openalex.org/W2010714081","https://openalex.org/W1942813046","https://openalex.org/W3021272328","https://openalex.org/W2115559375","https://openalex.org/W2122376846","https://openalex.org/W2167729602","https://openalex.org/W2001759324","https://openalex.org/W2560952055","https://openalex.org/W2115671963"],"abstract_inverted_index":{"Recently,":[0],"several":[1],"reports":[2],"have":[3,88],"indicated":[4],"instability":[5,24],"of":[6,31,50,77,102,112,140,154],"the":[7,11,18,26,98,110,115,146,152],"ecstasy":[8,32,56,69,107,148],"market":[9,149],"in":[10,25,41,52,142],"Netherlands":[12],"and":[13,68,74],"other":[14,125],"EU":[15],"countries.":[16],"In":[17,43,131],"current":[19],"study,":[20,93],"we":[21,45,94],"demonstrate":[22],"this":[23,78,92],"Netherlands,":[27],"showing":[28],"a":[29,47,58,172],"decrease":[30],"tablets":[33,53,70],"containing":[34],"3,4-methylenedioxymetamphetamine":[35],"(MDMA)":[36],"by":[37,57],"more":[38],"than":[39],"50%":[40],"2009.":[42],"addition,":[44],"describe":[46],"partial":[48],"replacement":[49],"MDMA":[51,159],"sold":[54,164],"as":[55,165],"previously":[59],"unseen":[60],"substance,":[61],"mephedrone":[62,103,136,155],"(or":[63],"4-methylmethcathinone).":[64],"Mephedrone":[65,118],"was":[66],"quantified":[67],"contained":[71],"between":[72],"96":[73],"155":[75],"mg":[76],"new":[79],"compound.":[80],"So":[81],"far,":[82],"no":[83],"studies":[84],"about":[85],"mephedrone's":[86],"effects":[87,101,116,122],"been":[89],"published.":[90],"For":[91],"gathered":[95],"information":[96],"on":[97],"acute":[99],"subjective":[100],"from":[104],"70":[105],"regular":[106],"users.":[108,144],"Overall,":[109],"majority":[111],"users":[113],"considered":[114],"enjoyable.":[117],"seemed":[119],"to":[120,124,133,156,170],"evoke":[121],"similar":[123],"amphetamine":[126],"type":[127],"psychostimulants,":[128],"including":[129],"MDMA.":[130],"contrast":[132],"MDMA,":[134],"however,":[135],"induced":[137],"strong":[138],"feelings":[139],"craving":[141],"most":[143],"If":[145],"unstable":[147],"situation":[150],"persists,":[151],"potential":[153],"substitute":[157],"for":[158,175],"might":[160],"be":[161,171],"substantial.":[162],"Mephedrone,":[163],"ecstasy,":[166],"is":[167],"therefore":[168],"likely":[169],"valid":[173],"cause":[174],"health":[176],"concern.":[177]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2102271024","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":29},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":17},{"year":2017,"cited_by_count":18},{"year":2016,"cited_by_count":17},{"year":2015,"cited_by_count":21},{"year":2014,"cited_by_count":24},{"year":2013,"cited_by_count":25},{"year":2012,"cited_by_count":26}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
